MRI Interventions Stock Price, News & Analysis (OTCMKTS:MRIC)

$2.55 0.03 (1.19 %)
(As of 01/21/2018 10:50 AM ET)
Previous Close$2.55
Today's Range$2.40 - $2.62
52-Week Range$1.76 - $7.40
Volume6,724 shs
Average Volume17,867 shs
Market Capitalization$26.21 million
P/E Ratio-1.75
Dividend YieldN/A

About MRI Interventions (OTCMKTS:MRIC)

MRI Interventions, Inc. (MRI Interventions), formerly SurgiVision, Inc., is a medical device company that develops and commercializes platforms for procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. The Company has two product platforms. Its ClearPoint system, which is in commercial use in the United States, is used to perform minimally invasive surgical procedures in the brain. Its ClearTrace system, which is still in development, will be used to perform minimally invasive surgical procedures in the heart. Both systems utilize intra-procedural magnetic resonance imaging to guide the procedures. Both systems are designed to work in a hospital's existing MRI suite. Its ClearPoint system is designed to allow minimally invasive procedures in the brain to be performed in a hospital's existing MRI suite. MRI Interventions's ClearTrace system is designed to deliver therapies to treat certain cardiac diseases.

Receive MRIC News and Ratings via Email

Sign-up to receive the latest news and ratings for MRIC and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical Appliances & Equipment


Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A


Trailing P/E Ratio-1.74657534246575
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A


Trailing EPSN/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A


Outstanding Shares10,340,000

MRI Interventions (OTCMKTS:MRIC) Frequently Asked Questions

What is MRI Interventions' stock symbol?

MRI Interventions trades on the OTCMKTS under the ticker symbol "MRIC."

How were MRI Interventions' earnings last quarter?

MRI Interventions Inc (OTCMKTS:MRIC) issued its quarterly earnings data on Monday, November, 6th. The company reported ($0.14) EPS for the quarter. View MRI Interventions' Earnings History.

Who are some of MRI Interventions' key competitors?

Who are MRI Interventions' key executives?

MRI Interventions' management team includes the folowing people:

  • Kimble L. Jenkins, Chairman of the Board (Age 55)
  • Joseph Michael Burnett, President, Chief Executive Officer, Director (Age 34)
  • Harold A. Hurwitz, Chief Financial Officer, Secretary (Age 65)
  • Peter G. Piferi, Chief Operating Officer (Age 57)
  • Wendelin C. Maners, Vice President - Sales and Marketing (Age 54)
  • R. John Fletcher, Director (Age 71)
  • Pascal E.R. Girin, Independent Director (Age 57)
  • Timothy T. Richards, Independent Director (Age 59)
  • Maria Degois Sainz, Independent Director (Age 51)
  • John N. Spencer Jr., CPA, Independent Director (Age 76)

How do I buy MRI Interventions stock?

Shares of MRI Interventions can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is MRI Interventions' stock price today?

One share of MRI Interventions stock can currently be purchased for approximately $2.55.

How big of a company is MRI Interventions?

MRI Interventions has a market capitalization of $26.21 million.

How can I contact MRI Interventions?

MRI Interventions' mailing address is 5 Musick, IRVINE, CA 92618-1638, United States. The company can be reached via phone at +1-949-9006833.

MarketBeat Community Rating for MRI Interventions (MRIC)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  12 (Vote Outperform)
Underperform Votes:  14 (Vote Underperform)
Total Votes:  26
MarketBeat's community ratings are surveys of what our community members think about MRI Interventions and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

MRI Interventions (OTCMKTS:MRIC) Analyst Ratings History

No equities research coverage for this company has been tracked by MarketBeat


MRI Interventions (OTCMKTS:MRIC) Earnings History and Estimates Chart

Earnings by Quarter for MRI Interventions (OTCMKTS:MRIC)

MRI Interventions (OTCMKTS MRIC) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/6/2017Q3 2017($0.14)ViewN/AView Earnings Details
8/1/2017Q2 2017($0.32)ViewN/AView Earnings Details
4/27/2017Q1 2017($0.46)$2.01 millionViewN/AView Earnings Details
2/28/2017Q4 2016($0.02)($0.47)$1.64 millionViewListenView Earnings Details
11/4/2016Q3 2016($0.70)ViewN/AView Earnings Details
8/15/2016Q2 2016($0.96)ViewN/AView Earnings Details
4/28/2016Q1 2016($0.80)ViewN/AView Earnings Details
3/23/2016Q4($0.02)($0.02)$1.51 millionViewListenView Earnings Details
11/3/2015Q3 2015($1.20)ViewN/AView Earnings Details
7/30/2015Q2 2015($1.60)ViewN/AView Earnings Details
4/30/2015Q1 2015($2.00)ViewN/AView Earnings Details
3/5/2015Q414($0.03)($0.03)$1.11 million$0.96 millionViewN/AView Earnings Details
11/13/2014Q3 2014($0.03)($0.06)$0.63 millionViewN/AView Earnings Details
8/7/2014Q2 2014($0.04)($0.03)$1.19 millionViewN/AView Earnings Details
5/8/2014Q1 2014$1.60ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)


MRI Interventions (OTCMKTS:MRIC) Earnings Estimates

No earnings estimates for this company have been tracked by


Dividend History for MRI Interventions (OTCMKTS:MRIC)

No dividend announcements for this company have been tracked by

Insider Trades

MRI Interventions (OTCMKTS MRIC) Insider Trading and Institutional Ownership History

Insider Trades by Quarter for MRI Interventions (OTCMKTS:MRIC)

MRI Interventions (OTCMKTS MRIC) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/12/2014John N Spencer JrDirectorBuy16,000$1.18$18,880.00View SEC Filing  
8/13/2014John N Spencer JrDirectorBuy3,500$1.00$3,500.00View SEC Filing  
6/13/2014Andrew K RookeDirectorBuy30,000$0.73$21,900.00View SEC Filing  
6/10/2014Andrew K RookeDirectorBuy50,000$0.78$39,000.00View SEC Filing  
8/19/2013Michael PietrangeloDirectorBuy100,000$1.27$127,000.00View SEC Filing  
6/11/2013Michael PietrangeloDirectorBuy41,855$1.10$46,040.50View SEC Filing  
5/13/2013John N Spencer JrDirectorBuy1,500$1.32$1,980.00View SEC Filing  
3/22/2013Bruce C ConwayDirectorBuy2,500$1.48$3,700.00View SEC Filing  
3/20/2013Bruce C ConwayDirectorBuy2,500$1.50$3,750.00View SEC Filing  
3/14/2013Bruce C ConwayDirectorBuy32,665$1.50$48,997.50View SEC Filing  
3/13/2013Bruce C ConwayDirectorBuy2,000$1.50$3,000.00View SEC Filing  
3/11/2013Bruce C ConwayDirectorBuy28,550$1.54$43,967.00View SEC Filing  
9/14/2012Bruce C ConwayDirectorBuy4,000$2.19$8,760.00View SEC Filing  
9/13/2012Bruce C ConwayDirectorBuy18,750$2.05$38,437.50View SEC Filing  
9/11/2012Bruce C ConwayDirectorBuy22,500$2.14$48,150.00View SEC Filing  
9/6/2012Bruce C ConwayDirectorBuy4,600$2.23$10,258.00View SEC Filing  
8/27/2012Bruce C ConwayDirectorBuy20,900$2.39$49,951.00View SEC Filing  
8/24/2012Bruce C ConwayDirectorBuy14,500$2.43$35,235.00View SEC Filing  
8/21/2012Bruce C ConwayDirectorBuy8,000$2.38$19,040.00View SEC Filing  
8/15/2012Bruce C ConwayDirectorBuy31,950$2.47$78,916.50View SEC Filing  
(Data available from 1/1/2013 forward)


MRI Interventions (OTCMKTS MRIC) News Headlines


SEC Filings

MRI Interventions (OTCMKTS:MRIC) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media


Financials are not available for this stock.


MRI Interventions (OTCMKTS MRIC) Stock Chart for Sunday, January, 21, 2018

Loading chart…

This page was last updated on 1/21/2018 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.